Company: IPSC
Filing Date: 2025-04-22
Form Type: DEF 14A
Source: 0001104659-25-037419
Chunk: 29

Company: Century Therapeutics, Inc.
Filing Date: 2025-04-22
Form: DEF 14A
Chunk 29
---
A or 14C of the Securities Exchange Act of 1934, as amended, or the Exchange Act, or (4) subject to the liabilities of Section 18 of the Exchange Act. This report shall not be deemed incorporated by reference into any of our other filings under the Exchange Act or the Securities Act of 1933, as amended, or the Securities Act, except to the extent that we specifically incorporate it by reference into such filing. THE AUDIT COMMITTEE OF THE
BOARD OF DIRECTORS OF
CENTURY THERAPEUTICS, INC. Daphne Quimi, Chairperson
Cynthia Butitta
Kimberly Blackwell, M.D.
Alessandro Riva, M.D. April 22, 2025 Notice of Annual Meeting of Stockholders and 2025 Proxy Statement | 19

TABLE OF CONTENTS

| ​ | EXECUTIVE OFFICERS | ​ |

The following table sets forth the name, age and position of each of our executive officers as of the date of this Proxy Statement:

| ​ | ​ | NAME                           | ​ | ​ | POSITION                                   | ​ | ​ | AGE | ​ | ​ |
| ​ | ​ | Brent Pfeiffenberger, Pharm.D. | ​ | ​ | President and Chief Executive Officer      | ​ | ​ |  47 | ​ | ​ |
| ​ | ​ | Morgan Conn, Ph.D.             | ​ | ​ | Chief Financial Officer                    | ​ | ​ |  56 | ​ | ​ |
| ​ | ​ | Gregory Russotti, Ph.D.        | ​ | ​ | Chief Technology and Manufacturing Officer | ​ | ​ |  58 | ​ | ​ |
| ​ | ​ | Adrienne Farid, Ph.D.          | ​ | ​ | Chief Development Officer                  | ​ | ​ |  63 | ​ | ​ |
| ​ | ​ | Chad Cowan, Ph.D.              | ​ | ​ | Chief Scientific Officer                   | ​ | ​ |  53 | ​ | ​ |

Brent Pfeiffenberger, Pharm.D.For biographical information for Dr. Pfeiffenberger, see “Board of Directors — Directors Nominees.” Morgan Conn, Ph.D. has served as our Chief Financial Officer since October 2024. Dr. Conn previously served as the Chief Business Officer of Pharvaris N.V. from November 2017 until October 2024. Prior to this, Dr. Conn worked at PTC Ther